Skip to main content

Peer Review reports

From: Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials

Original Submission
24 Dec 2021 Submitted Original manuscript
28 Jan 2022 Reviewed Reviewer Report
5 Feb 2022 Reviewed Reviewer Report
17 Feb 2022 Author responded Author comments - Bangwei Cao
Resubmission - Version 2
17 Feb 2022 Submitted Manuscript version 2
22 Feb 2022 Author responded Author comments - Bangwei Cao
Resubmission - Version 3
22 Feb 2022 Submitted Manuscript version 3
23 Feb 2022 Author responded Author comments - Bangwei Cao
Resubmission - Version 4
23 Feb 2022 Submitted Manuscript version 4
3 Mar 2022 Reviewed Reviewer Report
3 Mar 2022 Reviewed Reviewer Report
6 Mar 2022 Author responded Author comments - Bangwei Cao
Resubmission - Version 5
6 Mar 2022 Submitted Manuscript version 5
Publishing
23 Mar 2022 Editorially accepted
26 Mar 2022 Article published 10.1186/s12885-022-09444-0

You can find further information about peer review here.

Back to article page